Karyopharm Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Karyopharm Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- KPTI
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001503802
Board of directors
-
Barry E. Greene · DirectorSince 2023
-
Chen Schor · DirectorSince 2023
-
Christy J. Oliger · DirectorSince 2023
-
Deepika Pakianathan · DirectorSince 2023
-
Garen G. Bohlin · DirectorSince 2023
-
Mansoor Raza Mirza · DirectorSince 2023
-
Peter Honig · DirectorSince 2023
-
Richard A. Paulson · Director · President and CEOSince 2023
-
Zhen Su · DirectorSince 2023
Chief executives
Richard A. Paulson
· President and CEO
Dates unknown
Board connections
6 of this board's directors also sit on 7 other boards.
- via Chen Schor
- via Garen G. Bohlin
- via Zhen Su
- via Deepika Pakianathan
- via Christy J. Oliger
- via Mansoor Raza Mirza
- via Christy J. Oliger
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 7, 2024 | Deepika Pakianathan Director | Open-market sale | −229,308 | $0.95 | $217,843 |
| Jun 7, 2024 | Deepika Pakianathan Director | Open-market sale | −2,240 | $0.95 | $2,128 |
| Jun 6, 2024 | Deepika Pakianathan Director | Open-market sale | −117,307 | $0.98 | $114,961 |
| Jun 6, 2024 | Deepika Pakianathan Director | Open-market sale | −1,145 | $0.98 | $1,122 |
| Jun 5, 2024 | Deepika Pakianathan Director | Open-market sale | −463,518 | $0.96 | $444,977 |
| Jun 5, 2024 | Deepika Pakianathan Director | Open-market sale | −4,526 | $0.96 | $4,345 |
| Jun 4, 2024 | Mason Michael Officer (EVP, CFO & Treasurer) | Open-market sale | −652 | $0.99 | $645 |
| Jun 4, 2024 | Richard A. Paulson Director, Officer (President and CEO) | Open-market sale | −3,592 | $0.99 | $3,556 |
| Jun 4, 2024 | Deepika Pakianathan Director | Open-market sale | −337,742 | $0.95 | $320,855 |
| Jun 4, 2024 | Deepika Pakianathan Director | Open-market sale | −3,298 | $0.95 | $3,133 |
| Jun 3, 2024 | Deepika Pakianathan Director | Open-market sale | −357,256 | $1.00 | $357,256 |
| Jun 3, 2024 | Deepika Pakianathan Director | Open-market sale | −3,488 | $1.00 | $3,488 |
| May 31, 2024 | Deepika Pakianathan Director | Open-market sale | −202,418 | $0.95 | $192,297 |
| May 31, 2024 | Deepika Pakianathan Director | Open-market sale | −1,976 | $0.95 | $1,877 |
| Mar 5, 2024 | Richard A. Paulson Director, Officer (President and CEO) | Open-market sale | −3,573 | $1.30 | $4,645 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.